Company / Total Assets
United Therapeutics Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$7.9B
FY2025
5-year range
$5.2B / $7.9B
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#24 of 214
Health Care
What the data says
United Therapeutics's total assets of $7.9B is higher than 89% of companies in the Health Care sector (FY2025). Total Assets has increased for 9 consecutive years, from $2.3B in FY2016 to $7.9B in FY2025.
Based on SEC 10-K filings.
$7.9B in FY2025 with a 5-year CAGR of +11.3%. Top quartile in the Health Care sector.
Improved from $7.2B to $7.9B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 214This company $7.9B Sector average $7.5B
▼
+5.5% above sector average
Key checks
Key Insights
- United Therapeutics's total assets has grown for 9 consecutive years.
- 5-year CAGR of +11.3%, indicating consistent growth.
- In FY2025, total assets increased 7.0% year-over-year.
- Ranks #24 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.9B | +7.0% |
| FY2024 | $7.4B | +2.7% |
| FY2023 | $7.2B | +18.6% |
| FY2022 | $6.0B | +16.9% |
| FY2021 | $5.2B | +12.0% |
| FY2020 | $4.6B | +17.9% |
| FY2019 | $3.9B | +15.1% |
| FY2018 | $3.4B | +18.1% |
| FY2017 | $2.9B | +23.8% |
| FY2016 | $2.3B | +6.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026